1. Home
  2. APGE vs PAGP Comparison

APGE vs PAGP Comparison

Compare APGE & PAGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$132.75

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Logo Plains GP Holdings L.P. Units representing Limited Partner Interests

PAGP

Plains GP Holdings L.P. Units representing Limited Partner Interests

HOLD

Current Price

$24.22

Market Cap

4.7B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
APGE
PAGP
Founded
2022
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Natural Gas Distribution
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
4.7B
IPO Year
2023
2013

Fundamental Metrics

Financial Performance
Metric
APGE
PAGP
Price
$132.75
$24.22
Analyst Decision
Strong Buy
Buy
Analyst Count
13
10
Target Price
$109.67
$22.11
AVG Volume (30 Days)
4.9M
1.4M
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
6.90%
EPS Growth
N/A
370.00
EPS
N/A
0.27
Revenue
N/A
$44,262,000,000.00
Revenue This Year
N/A
$10.57
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$89.85
Revenue Growth
N/A
N/A
52 Week Low
$34.34
$16.69
52 Week High
$133.16
$26.15

Technical Indicators

Market Signals
Indicator
APGE
PAGP
Relative Strength Index (RSI) 81.33 52.32
Support Level $73.70 $22.78
Resistance Level $133.16 $24.25
Average True Range (ATR) 2.11 0.47
MACD 3.45 0.03
Stochastic Oscillator 99.20 66.04

Price Performance

Historical Comparison
APGE
PAGP

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About PAGP Plains GP Holdings L.P. Units representing Limited Partner Interests

Plains GP Holdings LP owns and operates midstream energy infrastructure and provides logistics services for crude oil, natural gas liquids (NGL), and natural gas. The group manages its operations through two operating segments: Crude Oil segment operations generally consist of gathering and transporting crude oil using pipelines (including gathering systems), trucks, and, at times, on barges or railcars; and NGL segment operations involve NGL storage and terminalling from NGL assets located in the Southwestern United States. It generates the majority of its revenue from the Crude Oil segment. Its geographic markets are the United States and Canada. It generates the majority of its revenue from the United States.

Share on Social Networks: